SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System for venous thromboembolism (VTE), a novel treatment solution intended to provide ...

A fuller picture of protein S deficiency emerged with large-scale research showing the immense thrombotic risks faced by carriers of rare loss-of-function gene variants, though patients with ...

Using a large U.S. health care claims database, we found that 1.58% of hospitalized medically ill patients-or about one in every 63 such admissions-develop clinical VTE over 90 days. The ...